Carole Pissot-Soldermann

5PUBLICATIONS
10CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsPharmaceutical delivery technologiesMolecular targetsMedical devicesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 19, 2023
Discovery of New Binders for DCAF1, an Emerging Ligase Target in the Targeted Protein Degradation Field.

Anna Vulpetti, Philipp Holzer, Niko Schmiedeberg

|Sep 07, 2022
Paradoxical Increase of Permeability and Lipophilicity with the Increasing Topological Polar Surface Area within a Series of PRMT5 Inhibitors.

Upendra Argikar, Markus Blatter, Dallas Bednarczyk

|Mar 30, 2022
Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies.

Ying Huang, Martin Sendzik, Jeff Zhang

|Nov 30, 2020
Discovery of Potent, Highly Selective, and In Vivo Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing.

Carole Pissot Soldermann, Oliver Simic, Martin Renatus

|Nov 20, 2020
Optimization of the In Vivo Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood.

Jean Quancard, Oliver Simic, Carole Pissot Soldermann

Pageof 1

Frequent Collaborators

2 joint publications

Ansgar Schuffenhauer

1 joint publications

Jean Quancard

1 joint publications

Eva Altmann

1 joint publications

Klemens Hoegenauer